| AiRuiKang (dalpiciclib) / Jiangsu Hengrui Pharma |
ChiCTR2000031608: SHR6390 in Treating Patients with Recurrent and/or Metastatic Mucosal Melanoma of Head and Neck Harboring CDK4 Amplification |
|
|
| Recruiting | N/A | 16 | | SHR6390 | Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine; Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, The clinical research drug SHR 6390 and insurances were provided to the subjects free of charge by Jiangsu Hengrui Medicine Co. Ltd. | Mucosal Melanoma of Head and Neck | | | | |
NCT06344780: Abemaciclib, Palbociclib or Dalpiciclib Combined With Endocrine Therapy as First-line Treatment in HR Positive, HER2 Negative Unresectable or Metastatic Breast Cancer |
|
|
| Recruiting | N/A | 150 | RoW | | Fudan University | Breast Cancer | 10/24 | 11/24 | | |
NCT05132790: Breast Cancer Study of Stereotactic Body Radiation Therapy (SBRT) Combined Neoadjuvant Treatment |
|
|
| Active, not recruiting | N/A | 24 | RoW | SHR-1316 at a dose 20mg/kg q3w, SHR6390 at a dose of 150mg orally, daily, SBRT | Shengjing Hospital, Jiangsu HengRui Medicine Co., Ltd. | Breast Cancer | 12/24 | 12/28 | | |
ChiCTR2100052636: Study to Evaluate the Efficacy and Safety of stereotactic body radiation therapy (SBRT) combined neoadjuvant treatment for patients with triple-negative and hormone receptor-positive, HER2-negative breast cancer |
|
|
| Not yet recruiting | N/A | 24 | | stereotactic body radiation therapy ;Combination of SBRT and SHR6390 plus endocrine therapy | Shengjing Hospital of China Medical University; Shengjing Hospital of China Medical University, No | Breast cancer | | | | |
ChiCTR2100046099: Clinical trial of an umbrella study of precise treatment of bone and soft tissue sarcoma based on molecular pathways |
|
|
| Recruiting | N/A | 51 | | SHR-1701+Famitinib ;Camrelizumab+SHR-6390 ;SHR-2554 | Affiliated Sixth People's Hospital, Shanghai Jiaotong University; Affiliated Sixth People's Hospital, Shanghai Jiaotong University, self-funded | advanced bone and soft tissue sarcoma | | | | |
| Not yet recruiting | N/A | 103 | RoW | dalpiciclib | RenJi Hospital | Advanced Breast Cancer | 12/25 | 12/28 | | |
